drugset / Trial / NCT01348165

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers

NCT01348165 ↗

Phase 1 Terminated 40 enrolled Boehringer Ingelheim
RandomizedSingle-groupSingle-blindTreatment

Summary

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers

Timeline

Start
2011-05
Primary completion
2011-08
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 137882 Unknown — Oral

Indications

No indication recorded.